
Shrimp stocks Avanti Feeds, Waterbase, others slide up to 5% after Trump slaps 50% tariffs on Indian exports
Live Events
Room for negotiation?
(You can now subscribe to our
(You can now subscribe to our ETMarkets WhatsApp channel
Shares of India's leading shrimp exporters fell as much as 5% on Thursday after U.S. President Donald Trump announced a fresh wave of tariffs on Indian goods, raising duties to 50%, among the highest imposed on any trading partner, in retaliation for India's continued oil trade with Russia.Avanti Feeds, Apex Frozen Foods and Waterbase Ltd bore the brunt of the market reaction as investors weighed the implications of heightened trade tensions. Shares of Avanti Feeds dropped 5.3% to Rs 631.80, Apex Frozen Foods slid 4% to Rs 218.80, while Waterbase Ltd declined nearly 2% to Rs 48.18.The tariff escalation, which builds on an earlier 25% levy imposed by the Trump administration, adds further strain to select Indian export sectors with deep exposure to the U.S. market. While only about 20% of India's goods exports, or 2% of GDP, are U.S.-bound, the impact on specific categories such as seafood, pharmaceuticals, and textiles is expected to be significant.The new tariffs will take effect in 21 days, according to the White House order, while the previously announced 25% duties are set to begin from Thursday.The tariff move underscores a marked deterioration in the relationship between Washington and New Delhi since the much-publicised February meeting between Trump and Prime Minister Narendra Modi. In recent weeks, Trump has publicly referred to India's economy as 'dead,' branded its trade barriers 'obnoxious,' and accused it of 'profiting' from cheap Russian oil while remaining silent on Russia's war in Ukraine, now in its fourth year.India's Ministry of External Affairs called the move 'extremely unfortunate,' and pointed out that 'many other countries are also importing Russian oil in their national economic interest.'Trade between the world's largest and fifth-largest economies is valued at over $190 billion, according to Reuters, and the latest escalation throws a spotlight on the frictions that could derail a steadily growing bilateral economic relationship.'The 21-day window for the additional 25% tariff to take effect leaves room for negotiation and an eventual deal with the US. But there is huge uncertainty surrounding the trade policy and to what extent both nations will be willing to make compromises," said Dr. VK Vijayakumar, Chief Investment Strategist at Geojit Financial Services Vijayakumar said that 'President Trump, fresh from the successes he has extracted in deals with others including the EU, is unlikely to budge significantly from his unjustified stand. Unfortunately for India, the U.S. is bargaining from a position of strength. India's response has been mature and measured.'On the broader market outlook, Vijayakumar said, 'The market is unlikely to panic but weakness will continue in the near-term. Since uncertainty is high investors should be cautious in their approach. At least in the near-term, export-oriented sectors will remain weak. Domestic consumption themes like banking and financials, telecom, hotels, cement, capital goods and segments of automobiles will remain resilient.'A day before the announcement, the Reserve Bank of India maintained its GDP growth forecast at 6.5% for the fiscal year, signalling that policymakers are not yet factoring in a material slowdown from trade-related tensions.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hans India
15 minutes ago
- Hans India
Advanced ortho implant manufacturing facility to be housed in AMTZ
Visakhapatnam: Ina landmark collaboration that spans three continents, OIC International (USA), Medi Mold, part of the Andhra Pradesh Medtech Zone (AMTZ) (India), and AddUp, a subsidiary of Fives Group (France) announced a strategic partnership to establish India's most advanced orthopaedic implant manufacturing facility. This trilateral arrangement marks a decisive step towards transforming India into a global hub for high-performance orthopaedic implants while aligning with the Indian government's 'Make in India' and medical self-reliance initiatives. Powered by 3D-printing and precision engineering, the facility will be housed in AMTZ, India's flagship medical device manufacturing park. OIC is launching the first-of-its-kind line of implants manufactured in India using advanced additive 3D technology designed for both domestic and global markets. Developed with proprietary technology, these implants aim to significantly reduce post-surgery recovery time while delivering cutting-edge solutions at a fraction of the cost and can be produced on a mass scale, close to the delivery points. 'This partnership reflects our commitment to making world-class orthopaedic implants affordable and accessible in India,' said Shetty, CEO of OIC International. Further, the CEO stated that India is a key strategic market, and 3D printing is the platform that enables them to innovate, lower costs, and meet the country's growing surgical needs. 'By manufacturing locally at AMTZ, we align with the government of India's Make in India vision delivering global-quality care to Indian patients,' he emphasised. At the core of the initiative is AddUp's cutting-edge metal additive manufacturing technology, which will serve as the backbone of the new facility. By enabling the production of geometrically complex, patient-specific implants with reduced material waste, 3D printing introduces a paradigm shift in how orthopaedic devices are designed, validated, and brought to market. The first metal 3D printer from AddUp's FormUp range will be installed at AMTZ, enabling rapid prototyping and market entry. This infrastructure, operated by Medi Mold, will ensure speed, flexibility, and efficiency in manufacturing, a vital combination for meeting the growing orthopaedic demand in India and abroad. 'Orthopaedic implants have traditionally been a business of machining. For the first time, 3D printing and modern manufacturing techniques are coming to play a role in modern implants. AMTZ and its scientific facilities, quality control systems and supporting infrastructure such as Gamma Sterilisation is the right place for 3D printed implant production in India. We look forward to making this a global supply chain benefiting patients with high quality implants,' underlined Jitendra Sharma, MD and CEO of AMTZ. Partnership of Medi Mold, Fives and OIC with AMTZ will create a global centre for 3D printed implants in India. Supporting innovation, equity, and market access through this partnership, the collaboration aims to address three fundamental challenges in orthopaedics. They include technology-led innovation, affordability and market access. The new facility will offer an integrated manufacturing platform for low-cost implants for public sector procurement, supporting government hospitals and healthcare schemes. Meanwhile, OIC will have the ability to support India's fast-growing private healthcare market. 'By joining forces with OIC International and Medi Mold, we're accelerating access to innovative, high-performance medical solutions through additive manufacturing,' said Julian Marcilly, president of AddUp.' The collaboration marks a strategic milestone for AddUp, enabling it to bring industrial metal 3D printing expertise to the Indian market and support the production of next-generation orthopaedic implants. Emphasising on the partnership built on shared vision, executive director at Wodehouse Capital Advisors, Mumbai, Sraboni Haralalka, said, 'We are proud to have been entrusted with the India Entry mandate by OIC International. This collaboration brings together leading innovators to disrupt the orthopaedic implant market in India by delivering cutting-edge technology at accessible prices.' Wodehouse Capital also noted significant investor interest, from both financial and strategic players, looking to tap into India's rapidly growing medical devices sector.


Hans India
15 minutes ago
- Hans India
Def tech co takes ‘Make in India, Make for the World' to Philippines
Bengaluru: In a move that reinforces Prime Minister Narendra Modi's vision of 'Make in India, Make for the World', and India's growing role as a global defence manufacturing hub, SMPP Limited, a leading Indian defence technology company, has signed a landmark Memorandum of Understanding (MoU) with Asia Defence and Firepower Corporation (ADFC) of the Philippines to establish a strategic joint venture corporation (JVC). The proposed JVC will be headquartered in the Philippines and focus on manufacturing, assembling, and distributing a range of SMPP's advanced defence products, tailored to support the Philippine government's Self-Reliant Defence Posture (SRDP) initiative under Republic Act No. 12024.


New Indian Express
15 minutes ago
- New Indian Express
US tariffs will hit Kerala's exports sector hard: Finance Minister Balagopal
THIRUVANANTHAPURAM: The US decision to impose a 50% tariff on Indian goods will have a serious impact on Kerala's economy as the state makes large-scale exports to the US, Finance Minister K N Balagopal has said. It is a bullying tactic to control the country's market, he said. 'Our exports to the US include shrimp and other fish produce, textiles, spices, cashew, coir, etc. Medical equipment too is exported in large quantities. Besides, there is modest export of semiconductors and chips. Software exports too will be affected,' he told reporters on Friday. 'The Prime Minister has said that strict measures would be taken in the wake of the US move. It is time for all to stand united and safeguard the country's interests,' he said. He urged the Union government to convene a meeting of all states to formulate strategies to protect the country's trade and economy. Calling the prohibitive tariff a ploy of the US to control the Indian market, he said,'They will ask India to rationalise our tax regime so that it can dump products in our market,' he said. The minister also said the tariff will have an impact on the labourers' wages and farmers' income. Companies will be forced to reduce wages and farmers will be forced to sell their produce at low rates. Balagopal criticised the Centre for its recent Bilateral Free Trade Agreement with the UK. Under this, import duty on luxury cars and liquor was reduced drastically.